Departamento de Fisiología

Departamento

Foto de Departamento de Fisiología

Foto de Marta

Marta
Llanos Muñoz

Publicaciones en las que colabora con Marta Llanos Muñoz (5)

2019

Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years
Leukemia and Lymphoma

2018

Efficacy and safety of vandetanib for patients with advanced and progressive medullary thyroid cancer (MTC) as systemic treatment beyond first-line therapy
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii476

2017

Impact of treatment in long-term survival patients with follicular lymphoma: A Spanish Lymphoma Oncology Group registry
PLoS ONE, Vol. 12, Núm. 5

2014

Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: A multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group
Leukemia and Lymphoma, Vol. 55, Núm. 1, pp. 51-55

2012

Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?
Clinical and Translational Oncology, Vol. 14, Núm. 5, pp. 386-390